| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Daisuke Tomizawa, Akifumi Endo, Michiko Kajiwara, Hirotoshi Sakaguchi, Kimikazu Matsumoto, Makoto Kaneda, Takashi Tag. Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia. Pediatric blood & cancer. vol 64. issue 8. 2017-09-14. PMID:28012245. |
patients with down syndrome (ds) are predisposed to acute myeloid leukemia (aml) and acute lymphoblastic leukemia (all) in early and later childhood, respectively, but rarely experience both. |
2017-09-14 |
2023-08-13 |
Not clear |
| Wasil Jastaniah, Abdulrahman Alsultan, Saad Al Daama, Walid Ballourah, Mohammad Bayoumy, Faisal Al-Anzi, Omar Al Shareef, Mohammed Burhan Abrar, Reem Al Sudairy, Ibrahim Al Ghemla. Treatment results in children with myeloid leukemia of Down syndrome in Saudi Arabia: A multicenter SAPHOS leukemia group study. Leukemia research. vol 58. 2017-09-14. PMID:28445808. |
despite the high incidence of down syndrome (ds) in arab countires, the incidence and outcomes of myeloid leukemia of ds (ml-ds) have not been studied. |
2017-09-14 |
2023-08-13 |
Not clear |
| J S Aller-Alvarez, M Menéndez-González, R Ribacoba-Montero, M Salvado, V Vega, R Suárez-Moro, M Sueiras, M Toledo, J Salas-Puig, J Álvarez-Sabi. Myoclonic epilepsy in Down syndrome and Alzheimer disease. Neurologia (Barcelona, Spain). vol 32. issue 2. 2017-09-12. PMID:25661268. |
patients with down syndrome (ds) who exhibit alzheimer disease (ad) are associated with age. |
2017-09-12 |
2023-08-13 |
Not clear |
| Catherine Do, Zhuo Xing, Y Eugene Yu, Benjamin Tyck. Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models. Epigenomics. vol 9. issue 2. 2017-09-11. PMID:27911079. |
here we review epigenetic effects of chromosomal aneuploidies, focusing on findings in down syndrome (ds, trisomy 21). |
2017-09-11 |
2023-08-13 |
mouse |
| Erik Hefti, Javier G Blanc. Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia. Journal of pediatric hematology/oncology. vol 38. issue 4. 2017-09-07. PMID:26907658. |
children with down syndrome (ds) have a 10- to 30-fold increased risk of developing acute myeloid leukemia or acute lymphoblastic leukemia. |
2017-09-07 |
2023-08-13 |
Not clear |
| Stefanos Aivazidis, Christina M Coughlan, Abhishek K Rauniyar, Hua Jiang, L Alexander Liggett, Kenneth N Maclean, James R Roed. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome. PloS one. vol 12. issue 4. 2017-09-07. PMID:28430800. |
down syndrome (ds) is a genetic disorder caused by trisomy of chromosome 21. |
2017-09-07 |
2023-08-13 |
mouse |
| Gisele F Bernardi, Carolina T F Pires, Nanci P Oliveira, Renato Nisihar. Prevalence of pressure equalization tube placement and hearing loss in children with down syndrome. International journal of pediatric otorhinolaryngology. vol 98. 2017-09-07. PMID:28583503. |
to determine the prevalence of pressure equalization tube (pet) placement and hearing loss in children with down syndrome (ds). |
2017-09-07 |
2023-08-13 |
Not clear |
| Fiorenza Stagni, Andrea Giacomini, Marco Emili, Stefania Trazzi, Sandra Guidi, Martina Sassi, Elisabetta Ciani, Roberto Rimondini, Renata Bartesagh. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. Neuroscience. vol 333. 2017-09-06. PMID:27457036. |
cognitive disability is an unavoidable feature of down syndrome (ds), a genetic disorder due to the triplication of human chromosome 21. |
2017-09-06 |
2023-08-13 |
mouse |
| Susan E Carozza, Harold Bae, Thomas Meath, Adam Branscum, Marit L Bovbjerg, Peter H Langloi. Evaluation of maternal health and labor and delivery conditions as risk factors for childhood leukemias in children with Down syndrome. Cancer epidemiology. vol 46. 2017-09-05. PMID:28012443. |
children with down syndrome (ds) have a remarkably high risk of developing leukemia during childhood; the mechanisms driving that risk are not well understood, and no clear prevention strategies exist. |
2017-09-05 |
2023-08-13 |
Not clear |
| Kris Ann P Schultz, Lu Chen, Alicia Kunin-Batson, Zhengjia Chen, William G Woods, Alan Gamis, Toana Kawashima, Kevin C Oeffinger, H Stacy Nicholson, Joseph P Negli. Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group. Journal of pediatric hematology/oncology. vol 39. issue 1. 2017-09-04. PMID:27906794. |
health-related quality of life (hr-qol) and chronic health conditions in survivors of childhood acute myeloid leukemia (aml) with down syndrome (ds): a report from the children's oncology group. |
2017-09-04 |
2023-08-13 |
human |
| Kris Ann P Schultz, Lu Chen, Alicia Kunin-Batson, Zhengjia Chen, William G Woods, Alan Gamis, Toana Kawashima, Kevin C Oeffinger, H Stacy Nicholson, Joseph P Negli. Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group. Journal of pediatric hematology/oncology. vol 39. issue 1. 2017-09-04. PMID:27906794. |
survival rates for children with down syndrome (ds) and acute myeloid leukemia (aml) are high; however, little is known regarding the health-related quality of life (hr-qol) of these survivors. |
2017-09-04 |
2023-08-13 |
human |
| Wei Xu, April M Weissmiller, Joseph A White, Fang Fang, Xinyi Wang, Yiwen Wu, Matthew L Pearn, Xiaobei Zhao, Mariko Sawa, Shengdi Chen, Shermali Gunawardena, Jianqing Ding, William C Mobley, Chengbiao W. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. The Journal of clinical investigation. vol 126. issue 5. 2017-08-31. PMID:27064279. |
the endosome/lysosome pathway is disrupted early in the course of both alzheimer's disease (ad) and down syndrome (ds); however, it is not clear how dysfunction in this pathway influences the development of these diseases. |
2017-08-31 |
2023-08-13 |
mouse |
| Iveta Svobodová, Marie Korabečná, Pavel Calda, Miroslav Břešťák, Eva Pazourková, Šárka Pospíšilová, Miroslava Krkavcová, Michaela Novotná, Aleš Hoříne. Differentially expressed miRNAs in trisomy 21 placentas. Prenatal diagnosis. vol 36. issue 8. 2017-08-31. PMID:27323694. |
molecular pathogenesis of down syndrome (ds) is still incompletely understood. |
2017-08-31 |
2023-08-13 |
Not clear |
| Pratiksha Tilak Rao, Vasudeva Guddattu, John Michael Solomo. Response abilities of children with Down Syndrome and other intellectual developmental disorders. Experimental brain research. vol 235. issue 5. 2017-08-30. PMID:28236089. |
to answer this question, we assessed the response abilities in terms of response time(rt) and response force(rf) among children with down syndrome(ds), intellectual developmental disorders(idd) and those who are typically developing. |
2017-08-30 |
2023-08-13 |
human |
| P Lee, R Bhansali, S Izraeli, N Hijiya, J D Crispin. The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome. Leukemia. vol 30. issue 9. 2017-08-29. PMID:27285583. |
children with down syndrome (ds) are at a 20-fold increased risk for acute lymphoblastic leukemia (ds-all). |
2017-08-29 |
2023-08-13 |
Not clear |
| I De Toma, L Manubens-Gil, S Ossowski, M Diersse. Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders. Neural plasticity. vol 2016. 2017-08-29. PMID:27547454. |
two examples are down syndrome (ds) and fragile x syndrome (fxs), where global and local epigenetic alterations lead to impairments in synaptic plasticity, memory, and learning. |
2017-08-29 |
2023-08-13 |
Not clear |
| Ayeswarya Ravikumar, Jason D Marsack, Julia S Benoit, Heather A Anderso. Simulated Keratometry Repeatability in Subjects with and without Down Syndrome. Optometry and vision science : official publication of the American Academy of Optometry. vol 93. issue 11. 2017-08-25. PMID:27741083. |
to assess the repeatability of simulated keratometry measures obtained with zeiss atlas topography for subjects with and without down syndrome (ds). |
2017-08-25 |
2023-08-13 |
human |
| Toshihiko Nakamura, Tomoaki Nomura, Takashi Kamohara, Hidehiro Takahashi, Daisuke Hatanaka, Michiko Kusakari, Mari Nakamura, Kinuyo Kawabata, Hitoshi Oht. DOWN'S SYNDROME WITH NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO HLA-A2 ANTIBODY. Fukushima journal of medical science. vol 61. issue 2. 2017-08-24. PMID:26632192. |
here a male baby, who was admitted for low birth weight with down syndrome (ds), was suffered from thrombocytopenia without transient myeloproliferative disorder (tmd). |
2017-08-24 |
2023-08-13 |
Not clear |
| Kassandra M Ori-McKenney, Richard J McKenney, Hector H Huang, Tun Li, Shan Meltzer, Lily Yeh Jan, Ronald D Vale, Arun P Wiita, Yuh Nung Ja. Phosphorylation of β-Tubulin by the Down Syndrome Kinase, Minibrain/DYRK1a, Regulates Microtubule Dynamics and Dendrite Morphogenesis. Neuron. vol 90. issue 3. 2017-08-22. PMID:27112495. |
dendritic arborization patterns are consistent anatomical correlates of genetic disorders such as down syndrome (ds) and autism spectrum disorders (asds). |
2017-08-22 |
2023-08-13 |
Not clear |
| Csaba Galambos, Angela D Minic, Douglas Bush, Dominique Nguyen, Blair Dodson, Gregory Seedorf, Steven H Abma. Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension. PloS one. vol 11. issue 8. 2017-08-21. PMID:27487163. |
infants with down syndrome (ds) or trisomy 21, are at high risk for developing pulmonary arterial hypertension (pah), but mechanisms that increase susceptibility are poorly understood. |
2017-08-21 |
2023-08-13 |
human |